文献速递细胞病理与分子病理神经与头颈病理

米兰系统唾液腺不确定恶性潜能肿瘤的组织学随访与恶性风险分析

Analysis of histologic follow-up and risk of malignancy for salivary gland neoplasm of uncertain malignant potential proposed by the Milan System for Reporting Salivary Gland Cytopathology.
PubMed 文献 · Cancer Cytopathol · 2018-04-18

NUMP总体恶性风险(ROM)为24.1%,BN组27.6%,SGNOC组20.0%,SGNOC组ROM与BN组相似但低于米兰系统提出的35%。

要点

  • NUMP总体恶性风险为24.1%,低于米兰系统提出的35%。
  • 基底样肿瘤组恶性风险27.6%,富嗜酸细胞肿瘤组20.0%。
  • NUMP需结合组织学随访区分基底样与嗜酸细胞肿瘤以评估风险。

核心结论

  • NUMP的恶性风险为24.1%,其中基底样肿瘤组为27.6%,富嗜酸细胞肿瘤组为20.0%。
  • 富嗜酸细胞肿瘤组恶性风险与基底样肿瘤组相似,但低于米兰系统提出的35%。

研究设计与样本

  • 回顾性分析2010至2016年656例唾液腺细针穿刺标本。

主要发现

  • 基底样肿瘤组组织学随访包括14例细胞性多形性腺瘤、5例基底细胞腺瘤、2例良性囊腺瘤、3例腺样囊性癌、3例上皮-肌上皮癌、1例基底细胞腺癌和1例肌上皮癌。
  • 富嗜酸细胞肿瘤组组织学随访包括7例结节性嗜酸细胞增生、6例Warthin瘤、5例嗜酸细胞瘤、1例皮脂腺腺瘤、1例黏液性囊腺瘤、2例腺泡细胞癌、2例黏液表皮样癌和1例乳腺类似分泌癌。
  • NUMP总体恶性风险为24.1%,基底样肿瘤组为27.6%,富嗜酸细胞肿瘤组为20.0%。

关键数值与推荐

  • 基底样肿瘤组恶性风险27.6%,富嗜酸细胞肿瘤组20.0%。
  • 米兰系统提出的NUMP恶性风险为35%。

临床怎么用

  • 对NUMP病例应结合组织学随访评估恶性风险,尤其需区分基底样与富嗜酸细胞肿瘤。
  • NUMP总体恶性风险低于米兰系统预期,可辅助临床决策但需结合其他因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Milan System for Reporting Salivary Gland Cytopathology is a tiered classification scheme that includes 6 diagnostic categories. Neoplasm, which is 1 of the 6 proposed categories, consists of benign neoplasm and neoplasm of uncertain malignant potential (NUMP). NUMP is reserved for a salivary gland neoplasm without clear distinction between benign and malignant. The objective of this study was to assess the risk of malignancy (ROM) of NUMP. METHODS: A retrospective analysis was conducted on 656 salivary gland fine-needle aspiration specimens from 2010 to 2016. Cases that qualified as NUMP and had follow-up surgical resections were reviewed and reclassified into basaloid neoplasm (BN) and salivary gland neoplasm with predominant oncocytic cell (SGNOC) groups. The ROM for each group was calculated. Fifty-four salivary gland fine-needle aspirations of NUMP that had surgical follow-up were identified, which included 29 BNs and 25 SGNOCs. RESULTS: Histologic follow-up for the BN group identified 14 cellular pleomorphic adenomas, 5 basal cell adenomas, 2 benign cystadenomas, 3 adenoid cystic carcinomas, 3 epithelial and myoepithelial carcinomas, 1 basal cell adenocarcinoma, and 1 myoepithelial carcinoma. Histologic follow-up for the SGNOC group revealed 7 nodular oncocytoses, 6 Warthin tumors, 5 oncocytomas, 1 sebaceous adenoma, 1 mucinous cystadenoma, 2 acinic cell carcinomas, 2 mucoepidermoid carcinomas, and 1 mammary analog secretory carcinoma. The ROM was calculated at 24.1% for the NUMP category overall (27.6% for BNs and 20.0% for SGNOCs). CONCLUSIONS: The ROM of the SGNOC group is similar to that of the BN group but lower than the ROM (35%) proposed by the Milan system. Cancer Cytopathol 2018. © 2018 American Cancer Society.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Liu H, Ljungren C, Lin F, et al. Analysis of histologic follow-up and risk of malignancy for salivary gland neoplasm of uncertain malignant potential proposed by the Milan System for Reporting Salivary Gland Cytopathology. Cancer Cytopathol. 2018. PMID: 29669190. doi:10.1002/cncy.22002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。